🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Enrique Álvarez

Rocky Mountain MS Center

ORCID: 0000-0001-5854-9643

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.4Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS

Neurology Clinical Practice(2020)10.1212/cpj.0000000000000800

Top 15%

1.4DataRank

Top 15%21 citations

John Rose, Enrique Álvarez, Amit Bar‐Or, Helmut Butzkueven, Robert J. Fox +17 more

Papers

Driven by 15 papers — median percentile 85. Top paper: “Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS”.

Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS

Neurology Clinical Practice(2020)10.1212/cpj.0000000000000800

Top 15%

1.4DataRank

Top 15%21 citations

John Rose, Enrique Álvarez, Amit Bar‐Or, Helmut Butzkueven, Robert J. Fox +17 more

The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome

Multiple Sclerosis and Related Disorders(2022)10.1016/j.msard.2022.104143

N/A

0.650DataRank · unranked

16 citations

Le H. Hua, Ellen M. Mowry, Susan A. Gauthier, Enrique Álvarez, Anne H. Cross +6 more

Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial

NeuroImage Clinical(2021)10.1016/j.nicl.2021.102834

N/A

0DataRank · unranked

61 citations

Pascal Sati, Praneeta Raza, Megan Kilbane, Elaina Gombos, Enrique Álvarez +23 more

Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002449

N/A

0DataRank · unranked

44 citations

Rodabe N. Amaria, Amer Najjar, Laszlo Radvanyi, Cara Haymaker, Marie-Andrée Forget +18 more

Metabolic costs of walking and arm reaching in persons with mild multiple sclerosis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.31.506034

N/A

0DataRank · unranked

2 citations

Enrique Álvarez, Roger M. Enoka, Alaa A. Ahmed, Robert J. Courter

Multiple sclerosis plasma IgG aggregates induce complement-dependent neuronal apoptosis

Cell Death and Disease(2023)10.1038/s41419-023-05783-3

N/A

0DataRank · unranked

26 citations

Michael W. Graner, Petr Pauček, Cheryl L. Beseler, Matthew L. Boisen, Andrew N. Bubak +8 more

Feasibility of Low-Load Resistance Training Using Blood Flow Restriction for People With Advanced Multiple Sclerosis: A Prospective Cohort Study

Physical Therapy(2023)10.1093/ptj/pzad135

N/A

0DataRank · unranked

15 citations

Evan T. Cohen, Enrique Álvarez, Emily R. Hager, Johnny G. Owens, Michael Bade +1 more

Plasma IgG aggregates as biomarkers for multiple sclerosis

Clinical Immunology(2023)10.1016/j.clim.2023.109801

N/A

0DataRank · unranked

10 citations

Michael W. Graner, Cheryl L. Beseler, Timothy Domashevich, Sean Selva, Gill Webster +6 more

Metabolic costs of walking and arm reaching in persons with mild multiple sclerosis

Journal of Neurophysiology(2023)10.1152/jn.00373.2022

N/A

0DataRank · unranked

10 citations

Enrique Álvarez, Roger M. Enoka, Alaa A. Ahmed, Robert J. Courter

Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis

Annals of Clinical and Translational Neurology(2023)10.1002/acn3.51745

N/A

0DataRank · unranked

8 citations

Haley Simpson, Eric Engebretson, Stefan Sillau, Brooke Valdez, José Parra‐González +15 more

Senescent-like microglia limit remyelination through the senescence associated secretory phenotype

Nature Communications(2025)10.1038/s41467-025-57632-w

N/A

0DataRank · unranked

43 citations

Violeta Durán‐Laforet, Low Tone Ho, George S. Melchor, Sameera Zia, Zeeba Manavi +10 more

From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis

Annals of Neurology(2025)10.1002/ana.78047

N/A

0DataRank · unranked

1 citations

Péter Kósa, Mark Greenwood, Enrique Álvarez, Christine Freedman, Anne H. Cross +6 more

Proteomic analysis of cerebrospinal fluid from females with multiple sclerosis highlights elevated microglial function and impaired neurogenesis

IBRO Neuroscience Reports(2025)10.1016/j.ibneur.2025.08.020

N/A

0DataRank · unranked

2 citations

Anthony J. Saviola, Enrique Álvarez, Kimberley D. Bruce, Dean Oldham

Shared decision-making for multiple sclerosis using the MS-SUPPORT tool: a plain language summary

Neurodegenerative Disease Management(2025)10.1080/17582024.2025.2493028

N/A

0DataRank · unranked

0 citations

Andrew Solomon, Enrique Álvarez, Lori Pbert, Carolina Ionete, Idanis Berrios Morales +8 more

Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era

Multiple Sclerosis and Related Disorders(2020)10.1016/j.msard.2020.102715

N/A

0DataRank · unranked

5 citations

Robert K. Shin, Enrique Álvarez, Barry Hendin, Kavita Nair, Fred Lublin +1 more